Lung Cancer: Fanny's Patient Story

Patient Info: Fanny, Female

Fanny was living with lung cancer after diagnosis in September 2016, had stopped work to focus on health, and described treatment as still effective while she stayed active with gentle exercise and support.

Lung Cancer: Julie's Survivor Story

Patient Info: Julie, Female, 70+

Julie had early-stage localized lung cancer without metastases, underwent right upper-lobe lobectomy and 6 chemotherapy treatments, and was told in October 2017 that she was in complete remission.

Lung Cancer: Carole's Survivor Story

Patient Info: Carole, Female, 70+

Carole’s mother was treated for lung cancer with lobectomy and chemotherapy and was later described as being in remission, active, exercising, and traveling.

Céline - Living With Lung Cancer

Patient Info: Fanny, Female

Fanny was living with lung cancer, fatigue, and ongoing medical appointments while her close friend Céline supported her through oncology visits and daily life.

Inoperable small cell lung cancer with brain metastases and treatment response

Patient Info: Anonymized, Male | Stage IV

Metastatic Site: Brain

After chemotherapy, radiation, and adjunct metabolic/complementary measures, the patient’s lung tumor shrank by 24%, later brain metastases disappeared on control scan, and arm function improved.

Lung Cancer: Sandra's Patient Story

Patient Info: Sandra, Female, 40s

Sandra was receiving immunotherapy for lung cancer and described the tumor as responding well and decreasing in size.

Stage IV Small Cell Lung Cancer: Sylvane's Patient Story

Patient Info: Sylvane, Female, 70+ | Stage IV

Metastatic Site: Bone; adrenal glands

After 3 chemotherapy cycles for Stage IV SCLC, Sylvane’s lung tumor had shrunk by half and bone and adrenal metastases had completely regressed, with a final chemo-immunotherapy cycle and then immunotherapy planned.

Stage IV Lung Cancer: Thierry's Survivor Story

Patient Info: Thierry, Male, 50s | Stage IV

Metastatic Site: Brain

Thierry had lung cancer with a brain metastasis treated with urgent brain surgery, radiotherapy, chemotherapy, and lung tumor surgery; later he lived under close surveillance after seizures and treatment-related recovery.

Aggressive lung cancer with bone metastases and concurrent localized breast cancer

Patient Info: Anonymized, Female | Stage IV

Metastatic Site: Bone: skull, spine, clavicle

The patient was still receiving carboplatin and Taxol for aggressive lung cancer with bone metastases, while her caregiver reported rapid clinical improvement, pain relief, disappearance of a visible forehead metastasis, and 1 cm reduction in a concurrent localized breast tumor.

Lung Cancer: Liz's Survivor Story

Patient Info: Liz, Female, 40s

Liz’s localized lung cancer was treated with surgery, chemotherapy, and 6 weeks of radiotherapy; by January 2016 her follow-up assessment was clear.

Lung Adenocarcinoma: Emmanuel's Survivor Story

Patient Info: Emmanuel, Male, 40s

Emmanuel was diagnosed with lung adenocarcinoma in January 2019, later reached remission, resumed work in a new role, and used peer support to separate home life from cancer life.

Small Cell Lung Cancer: Jean-Marc's Patient Story

Patient Info: Jean-Marc, Male, 50s

Jean-Marc was living after a diagnosis of small cell lung cancer, crediting care, research, family support, writing, and patient networks for helping him move forward.

Lung Cancer: François's Survivor Story

Patient Info: François, Male, 60s

François completed 20 radiation sessions and 6 chemotherapy sessions for lung cancer diagnosed in 2010 and later continued routine hospital checks every 6 months.

Stage IB lung cancer treated with left upper lobe resection and postoperative recovery story

Patient Info: Anonymized, Female | Stage I

After Stage IB lung cancer was treated with left upper lobe resection, she focused on recovery from significant postoperative pain; by about 2 months after surgery, the pain had greatly improved and she felt hopeful about regaining strength.

EGFR Non-Small Cell Lung Cancer: Donna's Patient Story

Patient Info: Donna Thompson, Female, 40s

Biomarkers: EGFR-positive lung cancer reported during recurrence; initial tumor biomarker status not reported

Recurrent NSCLC after earlier Stage II surgery and limited chemotherapy; later EGFR-targeted therapy caused kidney failure, 2 new spots were radiated in July 2025, and new nodules are under watchful monitoring.

GO2 FoundationRead more →

Stage IV EGFR Non-Small Cell Lung Cancer: Gerri's Patient Story

Patient Info: Gerri, Female | Stage IV

Biomarkers: EGFR-positive / EGFR-mutated

Metastatic Site: Not reported

Living actively with Stage IV EGFR-positive NSCLC after wedge resection and unnamed EGFR-directed targeted therapy, with major hiking and travel goals continuing after diagnosis.

Lung Cancer Research FoundationRead more →

Stage IV Non-Small Cell Lung Cancer: Usha's Patient Story

Patient Info: Usha Jain, Female | Stage IV

Biomarkers: Tumor genetic profile available for navigation review, but specific results are not reported

Stage IV NSCLC after nearly 2 years of chemotherapy and immunotherapy, followed by watchful monitoring with routine scans; clinical trials were reviewed but not pursued.

GO2 FoundationRead more →

Stage IV KRAS Non-Small Cell Lung Cancer: Maureen's Patient Story

Patient Info: Maureen, Female | Stage IV

Biomarkers: KRAS mutation

Metastatic Site: Not reported

Living with KRAS-mutated Stage IV lung cancer after initial Stage I diagnosis, later surgery, and radiation, while remaining active in KRAS and lung cancer advocacy.

Lung Cancer Research FoundationRead more →

Stage IV HER2-Positive Non-Small Cell Lung Cancer: Glenna's Survivor Story

Patient Info: Glenna, Female | Stage IV

Biomarkers: HER2 mutation confirmed by blood and tissue biopsy biomarker testing

Stage IV HER2-mutated NSCLC with first-line chemotherapy failure, then ongoing Enhertu from September 2023 and official NED/no evidence of disease status.

Lung Cancer Research FoundationRead more →

Stage I Lung Cancer: Jennifer's Survivor Story

Patient Info: Jennifer Rosato Perea, Female | Stage I

Cancer-free after February 2022 lower-right-lobe lobectomy for Stage I lung cancer, with no chemotherapy, radiation, or clinical trial treatment needed; returned to running and completed endurance events.

Lung Cancer Research FoundationRead more →

Stage IV EGFR Non-Small Cell Lung Cancer: Lexi's Patient Story

Patient Info: Lexi, Female, Under 40 | Stage IV

Biomarkers: EGFR exon 20 mutation

Metastatic Site: Bone — left leg and hip

Living with Stage IV EGFR exon 20 metastatic NSCLC involving bone, after chemotherapy, targeted therapy, a drug trial, and surgery to remove the primary lung mass; latest disease-control status is not clearly stated.

Lung Cancer Research FoundationRead more →

Stage IV Lung Cancer: Karen's Patient Story

Patient Info: Karen, Female, 40s | Stage IV

Biomarkers: Rare mutation affecting about 3% of lung cancer patients; mutation not named

Metastatic Site: Rib/bone involvement reported through recurrent tumor…

More than 8 years after initial Stage II lung cancer, Karen had a Stage IV recurrence requiring removal of a tumor and 2 ribs; she remained active and hopeful, but ongoing targeted treatment is not specifically stated.

Lung Cancer Research FoundationRead more →

Stage III EGFR Non-Small Cell Lung Cancer: Lauren's Survivor Story

Patient Info: Lauren, Female, Under 40 | Stage III

Biomarkers: EGFR mutation

No evidence of cancer on 1-year scan after fertility preservation, chemotherapy, radiation, and removal of half the left lung for Stage III EGFR-mutated lung cancer.

Lung Cancer Research FoundationRead more →

Laura Greco: Stage IV Lung Cancer

Patient Info: Laura Greco, Female | Stage IV

Biomarkers: ALK translocation / ALK-driven; MET amplification; EGFR amplification reported in brain tumor

Metastatic Site: Brain

Laura Greco passed away on July 14, 2024 after Stage IIIA ALK-driven lung cancer later metastasized to the brain and required repeated brain-directed treatment and targeted therapy.

Lung Cancer Research FoundationRead more →